Scientists Discover Gene Variant that Could Help Predict Chemo Outcomes

Scientists Discover Gene Variant that Could Help Predict Chemo Outcomes
Researchers have discovered new gene variants that affect how ovarian cancer patients respond to standard chemotherapy treatments Paraplatin (carboplatin) and Taxol (paclitaxel). The variants influence how a patient processes chemotherapy medications. For example, those who process medications faster are less likely to respond positively to treatment. Therefore, the variants could work as biomarkers of therapy response

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *